Holocene Advisors
ELV icon

Holocene Advisors’s Elevance Health ELV Stock Holding History

Holocene Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.75M Sell
12,293
-173,697
-93% -$64.4M 0.01% 426
2026
Q1 		$54.4M Buy
+185,990
New +$61.1M 0.13% 176
2024
Q4 		– Sell
-317,979
Closed -$165M – 787
2024
Q3 		$165M Buy
317,979
+40,778
+15% +$21.8M 0.67% 40
2024
Q2 		$150M Sell
277,201
-146,663
-35% -$77.5M 0.63% 48
2024
Q1 		$220M Buy
+423,864
New +$211M 0.81% 33
2023
Q3 		– Sell
-207,231
Closed -$92.1M – 762
2023
Q2 		$92.1M Sell
207,231
-131,914
-39% -$60.9M 0.39% 86
2023
Q1 		$156M Buy
339,145
+210,392
+163% +$100M 0.77% 32
2022
Q4 		$66M Sell
128,753
-130,871
-50% -$66.4M 0.4% 86
2022
Q3 		$118M Buy
259,624
+245,164
+1,695% +$117M 0.75% 42
2022
Q2 		$6.98M Sell
14,460
-75,547
-84% -$37.4M 0.04% 285
2022
Q1 		$44.2M Buy
+90,007
New +$41.1M 0.23% 134
2021
Q3 		– Sell
-176,476
Closed -$67.4M – 854
2021
Q2 		$67.4M Buy
176,476
+110,245
+166% +$42.1M 0.38% 96
2021
Q1 		$23.8M Sell
66,231
-190,414
-74% -$61.2M 0.15% 162
2020
Q4 		$82.4M Sell
256,645
-151,228
-37% -$46.4M 0.52% 52
2020
Q3 		$110M Sell
407,873
-150,039
-27% -$40.4M 0.83% 28
2020
Q2 		$147M Buy
557,912
+396,348
+245% +$106M 1.29% 14
2020
Q1 		$36.7M Buy
+161,564
New +$44M 0.39% 79
2019
Q3 		– Sell
-169,460
Closed -$47.8M – 744
2019
Q2 		$47.8M Buy
169,460
+42,768
+34% +$11.7M 0.61% 63
2019
Q1 		$36.4M Sell
126,692
-161,906
-56% -$46.8M 0.56% 60
2018
Q4 		$75.8M Buy
288,598
+189,512
+191% +$52.1M 1.22% 25
2018
Q3 		$27.2M Buy
99,086
+16,560
+20% +$4.3M 0.44% 75
2018
Q2 		$19.6M Buy
+82,526
New +$19.1M 0.42% 73

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Holocene Advisors's ELV Position: Q2 2026 in Review

Holocene Advisors reduced its Elevance Health (ELV) stake by 93% in Q2 2026, selling an estimated $64.4M and leaving 12,293 shares worth $4.75M. The position accounts for 0.01% of the portfolio, ranked #426.

Holocene Advisors first reported a position in ELV in Q2 2018 and has held it in 22 quarters since. The position peaked at $220M in Q1 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Holocene Advisors held 12,293 shares of Elevance Health worth $4.75M as of Q2 2026.
  • Holocene Advisors sold 173,697 Elevance Health shares in Q2 2026, an estimated $64.4M.
  • Elevance Health made up 0.01% of Holocene Advisors's portfolio in Q2 2026, its #426 holding.
  • Holocene Advisors first reported a position in Elevance Health in Q2 2018 and has held it in 22 quarters since.
  • Holocene Advisors's Elevance Health position peaked at $220M in Q1 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.